Literature DB >> 12051906

A new crystal form of the NK1 splice variant of HGF/SF demonstrates extensive hinge movement and suggests that the NK1 dimer originates by domain swapping.

Keiichi Watanabe1, Dimitri Y Chirgadze, Daniel Lietha, Hugo de Jonge, Tom L Blundell, Ermanno Gherardi.   

Abstract

NK1 is a splice variant of the polypeptide growth factor HGF/SF that consists of the N terminal (N) and first kringle (K) domains and retains receptor binding and signalling. While NK1 behaves as a monomer in solution, two independent crystallographic structures have previously shown an identical, tightly packed dimer. Here we report a novel orthorhombic crystal form of NK1 at 2.5 A resolution in which four NK1 protomers are packed in two distinct dimers in the asymmetric unit. Although the basic architecture of the new NK1 dimers is similar to the two described earlier, the new crystal form demonstrates extensive hinge movement between the N and K domain that leads to re-orientation of the receptor-binding sites. The hinge bending is evidence of the paucity of strong interactions between domains within the protomer, in contrast to the extensive interactions between protomers in the dimer. These observations are consistent with domain swapping in the dimer, such that the interdomain interactions of the monomer are replaced by equivalent interprotomer interactions in the dimer and offer a route for protein engineering of NK1 variants which may act as receptor antagonists. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051906     DOI: 10.1016/S0022-2836(02)00199-7

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist.

Authors:  Cassie J Liu; Douglas S Jones; Ping-Chuan Tsai; Abhishek Venkataramana; Jennifer R Cochran
Journal:  FEBS Lett       Date:  2014-11-21       Impact factor: 4.124

2.  A pilot study on nitration/dysfunction of NK1 segment of myogenic stem cell activator HGF.

Authors:  Alaa Elgaabari; Nana Imatomi; Hirochika Kido; Miyumi Seki; Sakiho Tanaka; Yuji Matsuyoshi; Takashi Nakashima; Shoko Sawano; Wataru Mizunoya; Takahiro Suzuki; Mako Nakamura; Judy E Anderson; Ryuichi Tatsumi
Journal:  Biochem Biophys Rep       Date:  2022-06-11

3.  Expression array analysis of the hepatocyte growth factor invasive program.

Authors:  Fabiola Cecchi; Chih-Jian Lih; Young H Lee; William Walsh; Daniel C Rabe; Paul M Williams; Donald P Bottaro
Journal:  Clin Exp Metastasis       Date:  2015-08-01       Impact factor: 5.150

4.  Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

Authors:  Ermanno Gherardi; Sara Sandin; Maxim V Petoukhov; John Finch; Mark E Youles; Lars-Göran Ofverstedt; Ricardo N Miguel; Tom L Blundell; George F Vande Woude; Ulf Skoglund; Dmitri I Svergun
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

Review 5.  State of the structure address on MET receptor activation by HGF.

Authors:  Edmond M Linossi; Gabriella O Estevam; Masaya Oshima; James S Fraser; Eric A Collisson; Natalia Jura
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

6.  Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding.

Authors:  A G Sigurdardottir; A Winter; A Sobkowicz; M Fragai; D Chirgadze; D B Ascher; T L Blundell; E Gherardi
Journal:  Chem Sci       Date:  2015-07-31       Impact factor: 9.825

7.  Structure of the Dual-Mode Wnt Regulator Kremen1 and Insight into Ternary Complex Formation with LRP6 and Dickkopf.

Authors:  Matthias Zebisch; Verity A Jackson; Yuguang Zhao; E Yvonne Jones
Journal:  Structure       Date:  2016-08-11       Impact factor: 5.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.